|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3630200A
(en)
|
1969-06-09 |
1971-12-28 |
Alza Corp |
Ocular insert
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US3914250A
(en)
|
1974-08-01 |
1975-10-21 |
American Home Prod |
1,4-Diazepino{8 6,5,4-jk{9 carbazoles
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
JPS608117B2
(ja)
|
1977-02-08 |
1985-02-28 |
財団法人微生物化学研究会 |
新生理活性物質エステラスチンおよびその製造法
|
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
JPS57151944A
(en)
|
1981-03-16 |
1982-09-20 |
Fuji Photo Film Co Ltd |
Color photosensitive silver halide material
|
|
ZA821577B
(en)
|
1981-04-06 |
1983-03-30 |
Boots Co Plc |
Therapeutic agents
|
|
US4452813A
(en)
|
1981-05-22 |
1984-06-05 |
Taiho Pharmaceutical Company Limited |
Sulfonate derivatives, process for preparing same and antilipemic compositions containing the derivative
|
|
JPS58193541A
(ja)
|
1982-05-07 |
1983-11-11 |
Konishiroku Photo Ind Co Ltd |
熱現像画像記録材料
|
|
JPH0245181B2
(ja)
|
1983-03-16 |
1990-10-08 |
Fuji Photo Film Co Ltd |
Netsugenzokaraakankozairyo
|
|
GB8313322D0
(en)
|
1983-05-14 |
1983-06-22 |
Ciba Geigy Ag |
Heterocyclic-(cyclo)aliphatic carboxylic acids
|
|
GB8313320D0
(en)
|
1983-05-14 |
1983-06-22 |
Ciba Geigy Ag |
Coating compositions
|
|
GB8313321D0
(en)
|
1983-05-14 |
1983-06-22 |
Ciba Geigy Ag |
Preparation of mercaptan substituted carboxylic acids
|
|
CA1247547A
(en)
|
1983-06-22 |
1988-12-28 |
Paul Hadvary |
Leucine derivatives
|
|
GB8412063D0
(en)
|
1984-05-11 |
1984-06-20 |
Ciba Geigy Ag |
Compositions containing heterocyclic corrosion inhibitors
|
|
GB8412065D0
(en)
|
1984-05-11 |
1984-06-20 |
Ciba Geigy Ag |
Preparation of carboxylic acid derivatives
|
|
GB8412064D0
(en)
|
1984-05-11 |
1984-06-20 |
Ciba Geigy Ag |
Compositions containing heterocyclic corrosion inhibitors
|
|
US4851423A
(en)
|
1986-12-10 |
1989-07-25 |
Schering Corporation |
Pharmaceutically active compounds
|
|
IE61928B1
(en)
|
1988-11-29 |
1994-11-30 |
Boots Co Plc |
Treatment of obesity
|
|
US5391571A
(en)
|
1989-11-15 |
1995-02-21 |
American Home Products Corporation |
Cholesterol ester hydrolase inhibitors
|
|
US5112820A
(en)
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
|
US5081122A
(en)
|
1990-03-05 |
1992-01-14 |
Sterling Drug Inc. |
Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof
|
|
US4973587A
(en)
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
|
US5013837A
(en)
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
|
JPH0427854A
(ja)
|
1990-05-23 |
1992-01-30 |
Mitsubishi Heavy Ind Ltd |
レーザ分析装置
|
|
SG64322A1
(en)
|
1991-05-10 |
1999-04-27 |
Rhone Poulenc Rorer Int |
Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
US5349056A
(en)
|
1992-10-09 |
1994-09-20 |
Regeneron Pharmaceuticals |
Modified ciliary neurotrophic factors
|
|
US6472178B1
(en)
|
1998-02-27 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
|
|
AU5118893A
(en)
|
1992-10-13 |
1994-05-09 |
Nippon Soda Co., Ltd. |
Oxazole and thiazole derivatives
|
|
US5451677A
(en)
|
1993-02-09 |
1995-09-19 |
Merck & Co., Inc. |
Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
|
|
US5292736A
(en)
|
1993-02-26 |
1994-03-08 |
Sterling Winthrop Inc. |
Morpholinoalkylindenes as antiglaucoma agents
|
|
JPH06298731A
(ja)
|
1993-04-13 |
1994-10-25 |
Fuji Photo Film Co Ltd |
複素環化合物の製造方法
|
|
DE4326151A1
(de)
|
1993-08-04 |
1995-02-09 |
Hoechst Ag |
Aromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
|
CA2134192A1
(en)
|
1993-11-12 |
1995-05-13 |
Michael L. Denney |
5, 6-bicyclic glycoprotein iib/iiia antagonists
|
|
FR2714057B1
(fr)
|
1993-12-17 |
1996-03-08 |
Sanofi Elf |
Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
|
|
US5705515A
(en)
|
1994-04-26 |
1998-01-06 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
|
|
IL113410A
(en)
|
1994-04-26 |
1999-11-30 |
Merck & Co Inc |
Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
|
|
WO1995029897A1
(en)
|
1994-04-29 |
1995-11-09 |
G.D. Searle & Co. |
METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
|
|
US5596025A
(en)
|
1994-06-30 |
1997-01-21 |
Minnesota Mining And Manufacturing Company |
Dental impression material with cure-indicating dye
|
|
AU692977B2
(en)
|
1994-11-07 |
1998-06-18 |
Pfizer Inc. |
Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands
|
|
US5605886A
(en)
|
1995-01-31 |
1997-02-25 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5554727A
(en)
|
1995-01-31 |
1996-09-10 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
CA2211656A1
(en)
|
1995-01-31 |
1996-08-08 |
Margret B. Basinski |
Anti-obesity proteins
|
|
FI973162L
(fi)
|
1995-01-31 |
1997-09-30 |
Lilly Co Eli |
Liikalihavuutta vastustavia proteiineja
|
|
US5552524A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5552522A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5559208A
(en)
|
1995-01-31 |
1996-09-24 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5521283A
(en)
|
1995-01-31 |
1996-05-28 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5552523A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5532237A
(en)
|
1995-02-15 |
1996-07-02 |
Merck Frosst Canada, Inc. |
Indole derivatives with affinity for the cannabinoid receptor
|
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
|
US20020006964A1
(en)
|
1995-05-16 |
2002-01-17 |
Young James W. |
Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds
|
|
US5739106A
(en)
|
1995-06-07 |
1998-04-14 |
Rink; Timothy J. |
Appetite regulating compositions
|
|
CA2204616C
(en)
|
1995-09-18 |
2002-12-17 |
Ranjan Mukherjee |
Ppar gamma antagonists for treating obesity
|
|
FR2741621B1
(fr)
|
1995-11-23 |
1998-02-13 |
Sanofi Sa |
Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
|
|
US6482927B1
(en)
|
1995-11-27 |
2002-11-19 |
Millennium Pharmaceuticals, Inc. |
Chimeric proteins comprising the extracellular domain of murine Ob receptor
|
|
AU1328197A
(en)
|
1995-12-01 |
1997-06-19 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
|
AU7692996A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Receptor antagonists
|
|
WO1997020822A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Quinazolin-2,4-diazirines as npy receptor antagonist
|
|
AU7626496A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Heteroaryl compounds
|
|
AU7692696A
(en)
|
1995-12-01 |
1997-06-27 |
Novartis Ag |
Heteroaryl derivatives
|
|
TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
|
WO1997028149A1
(en)
|
1996-02-02 |
1997-08-07 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
|
WO1997028137A1
(en)
|
1996-02-02 |
1997-08-07 |
Merck & Co., Inc. |
Heterocyclic derivatives as antidiabetic and antiobesity agents
|
|
AU721452B2
(en)
|
1996-02-02 |
2000-07-06 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
JP2002515865A
(ja)
|
1996-02-02 |
2002-05-28 |
メルク エンド カンパニー インコーポレーテッド |
抗糖尿病薬
|
|
ATE293963T1
(de)
|
1996-02-02 |
2005-05-15 |
Merck & Co Inc |
Verfahren zur behandlung von diabetes und verwandter krankheitszustände.
|
|
WO1997029079A1
(en)
|
1996-02-06 |
1997-08-14 |
Japan Tobacco Inc. |
Novel compounds and pharmaceutical use thereof
|
|
WO1997046556A1
(en)
|
1996-06-07 |
1997-12-11 |
Merck & Co., Inc. |
OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
|
|
JP2000516958A
(ja)
|
1996-08-26 |
2000-12-19 |
ジェネティックス・インスチチュート・インコーポレーテッド |
ホスホリパーゼ酵素の阻害剤
|
|
IT1288388B1
(it)
|
1996-11-19 |
1998-09-22 |
Angeletti P Ist Richerche Bio |
Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
|
|
CA2274594C
(en)
|
1996-12-16 |
2006-10-10 |
Banyu Pharmaceutical Co., Ltd. |
Aminopyrazole derivatives
|
|
JPH10237049A
(ja)
|
1996-12-24 |
1998-09-08 |
Nippon Chemiphar Co Ltd |
ベンズイソキサゾ−ル誘導体
|
|
DE69822449T2
(de)
|
1997-01-21 |
2005-01-27 |
Smithkline Beecham Corp. |
Neue cannabinoidrezeptor-modulatoren
|
|
ID22273A
(id)
|
1997-01-28 |
1999-09-23 |
Merck & Co Inc |
TIAZOL BENZENASULFONAMIDA SEBAGAI AGONIS β UNTUK PENGOBATAN DIABETES DAN OBESITAS
|
|
US6251947B1
(en)
|
1997-02-04 |
2001-06-26 |
Board Of Trustees Of The University Of Arkansas |
Fungicidal carboxamides
|
|
AU735137B2
(en)
|
1997-02-21 |
2001-07-05 |
Bayer Intellectual Property Gmbh |
Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders
|
|
US6284748B1
(en)
|
1997-03-07 |
2001-09-04 |
Metabasis Therapeutics, Inc. |
Purine inhibitors of fructose 1,6-bisphosphatase
|
|
US6054587A
(en)
|
1997-03-07 |
2000-04-25 |
Metabasis Therapeutics, Inc. |
Indole and azaindole inhibitors of fructose-1,6-bisphosphatase
|
|
DE69819311T2
(de)
|
1997-03-07 |
2004-07-29 |
Metabasis Therapeutics Inc., San Diego |
Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
|
|
US5948777A
(en)
|
1997-03-18 |
1999-09-07 |
Smithkline Beecham Corporation |
Cannabinoid receptor agonists
|
|
FR2761265B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
|
|
FR2761266B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
|
DE69812096T2
(de)
|
1997-04-23 |
2003-10-30 |
Banyu Pharmaceutical Co., Ltd. |
Neuropeptid y rezeptorantagonisten
|
|
US6001836A
(en)
|
1997-05-28 |
1999-12-14 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
|
|
BR9810745A
(pt)
|
1997-06-10 |
2001-03-13 |
Glaxo Group Ltd |
Derivados de benzimidazol
|
|
SE9702457D0
(sv)
|
1997-06-26 |
1997-06-26 |
Pharmacia & Upjohn Ab |
Screening
|
|
PL337888A1
(en)
|
1997-07-03 |
2000-09-11 |
Du Pont Pharm Co |
Imidazoprimidines and imidazopyridines for use in treating neurological disorders
|
|
KR20010021696A
(ko)
|
1997-07-11 |
2001-03-15 |
미즈노 마사루 |
퀴놀린 화합물 및 그의 의약용도
|
|
CN1280574A
(zh)
|
1997-10-27 |
2001-01-17 |
雷迪研究基金会 |
新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
|
|
WO1999019313A1
(en)
|
1997-10-27 |
1999-04-22 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
EP1051403A1
(en)
|
1998-01-29 |
2000-11-15 |
Dr. Reddy's Research Foundation |
Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
HUP0100156A3
(en)
|
1998-02-25 |
2002-12-28 |
Genetics Inst Inc Cambridge |
Indole derivatives as inhibitors of phospholipase a2 and use of them for producing pharmaceutical compositions
|
|
CA2322487C
(en)
|
1998-03-06 |
2010-07-20 |
Metabasis Therapeutics, Inc. |
Novel prodrugs for phosphorus-containing compounds
|
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
|
EP1068207A1
(en)
|
1998-04-02 |
2001-01-17 |
Neurogen Corporation |
AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES
|
|
BR9910583A
(pt)
|
1998-04-29 |
2001-01-09 |
Ortho Mcneil Pharm Inc |
Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios
|
|
JP2002507543A
(ja)
|
1998-05-27 |
2002-03-12 |
ドクター・レディーズ・リサーチ・ファウンデーション |
二環系化合物、その製造方法およびそれらを含有する薬学的組成物
|
|
US6329395B1
(en)
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
|
WO1999064002A1
(en)
|
1998-06-11 |
1999-12-16 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
|
HUP0103256A3
(en)
|
1998-07-15 |
2002-05-28 |
Teijin Ltd |
Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
|
|
HN1998000027A
(es)
|
1998-08-19 |
1999-06-02 |
Bayer Ip Gmbh |
Arilsulfonamidas y analagos
|
|
DE19837627A1
(de)
|
1998-08-19 |
2000-02-24 |
Bayer Ag |
Neue Aminosäureester von Arylsulfonamiden und Analoga
|
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
|
KR100818845B1
(ko)
|
1998-09-09 |
2008-04-01 |
메타베이시스 테라퓨틱스, 인크. |
신규한 프럭토스 1,6-비스포스파타제의 헤테로방향족 억제제
|
|
EP1109908B1
(en)
|
1998-09-10 |
2005-08-17 |
Millennium Pharmaceuticals, Inc. |
Methods for determining compounds for modulating the body weight
|
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
|
DE19844547C2
(de)
|
1998-09-29 |
2002-11-07 |
Aventis Pharma Gmbh |
Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US7417038B1
(en)
|
1998-10-15 |
2008-08-26 |
Imperial Innovations Limited |
Methods of treating cachexia
|
|
US6353018B1
(en)
|
1998-10-21 |
2002-03-05 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
EP1123269A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
EP1123292A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
ATE314371T1
(de)
|
1998-11-10 |
2006-01-15 |
Merck & Co Inc |
Spiro-indole als y5-rezeptor antagonisten
|
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
|
US6344481B1
(en)
|
1999-03-01 |
2002-02-05 |
Pfizer Inc. |
Thyromimetic antiobesity agents
|
|
MXPA01008937A
(es)
|
1999-03-05 |
2004-04-05 |
Metabasis Therapeutics Inc |
Nuevos profarmacos que contienen fosforo.
|
|
MXPA01009404A
(es)
|
1999-03-19 |
2004-03-19 |
Abbott Gmbh & Co Kg |
Metodo para tratar trastornos de alimentacion.
|
|
FR2792314B1
(fr)
|
1999-04-15 |
2001-06-01 |
Adir |
Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
|
AU775166B2
(en)
|
1999-04-22 |
2004-07-22 |
H. Lundbeck A/S |
Selective NPY (Y5) antagonists
|
|
HK1041263A1
(zh)
|
1999-05-05 |
2002-07-05 |
Ortho-Mcneil Pharmaceutical, Inc. |
可用於治疗肥胖和其他疾病的3a，4，5，9b-四氢-1h-苯并[e]吲-2-基胺衍生的神经肽y受体配体
|
|
AU778393B2
(en)
|
1999-05-12 |
2004-12-02 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyrazole carboxamides useful for the treatment of obesity and other disorders
|
|
CA2377369A1
(en)
|
1999-06-04 |
2000-12-14 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin-4 receptor agonists
|
|
MXPA01013199A
(es)
|
1999-06-30 |
2003-08-20 |
Tularik Inc |
Compuestos para la modulacion de la actividad de ppary.
|
|
EP1194421B1
(en)
|
1999-06-30 |
2005-10-12 |
H. Lundbeck A/S |
Selective npy (y5) antagonists
|
|
WO2001007409A1
(en)
|
1999-07-23 |
2001-02-01 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
|
WO2001009120A1
(en)
|
1999-07-28 |
2001-02-08 |
Ortho-Mcneil Pharmaceutical, Inc. |
Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
|
|
BR0012984A
(pt)
|
1999-08-04 |
2002-07-16 |
Millennium Pharm Inc |
Método para tratar um estado associado com o mc4-r em um mamìfero, composto de ligação ao mc4-r, e, composição farmacêutica
|
|
TWI279402B
(en)
|
1999-08-20 |
2007-04-21 |
Banyu Pharma Co Ltd |
Spiro compounds having NPY antagonistic activities and agents containing the same
|
|
WO2001021169A1
(en)
|
1999-09-20 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Mch antagonists
|
|
CA2379585C
(en)
|
1999-09-30 |
2006-06-20 |
James W. Darrow |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
|
PL354784A1
(en)
|
1999-09-30 |
2004-02-23 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
|
ES2277855T3
(es)
|
1999-09-30 |
2007-08-01 |
Neurogen Corporation |
Pirazolo-(1,5-a)-1,5-pirimidinas y pirazolo-(1,5-a)-1,3,5-triazinas amino sustituidas.
|
|
TWI262185B
(en)
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
|
CA2384378C
(en)
|
1999-10-06 |
2011-05-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
WO2001025192A1
(en)
|
1999-10-06 |
2001-04-12 |
Melacure Therapeutics Ab |
Guanidine derivatives and their use in the production of a medicament for blocking xanthine oxidase/dehydrogenase
|
|
WO2001027068A1
(en)
|
1999-10-13 |
2001-04-19 |
Pfizer Products Inc. |
Biaryl ether derivatives useful as monoamine reuptake inhibitors
|
|
DE19949319A1
(de)
|
1999-10-13 |
2001-06-13 |
Ruetgers Vft Ag |
Verfahren zur Herstellung von Arylalkylethern
|
|
CZ20021528A3
(cs)
|
1999-11-05 |
2002-07-17 |
Aventis Pharma Deutschland Gmbh |
Polycyklické deriváty dihydrothiazolu, způsob jejich přípravy a jejich pouľití jako léčiv
|
|
EP1237875B1
(en)
|
1999-12-16 |
2005-08-31 |
Schering Corporation |
Substituted imidazole neuropeptide y y5 receptor antagonists
|
|
US20030083315A1
(en)
|
2000-01-17 |
2003-05-01 |
Naoki Tsuchiya |
Human chymase inhibitors
|
|
ES2295128T3
(es)
|
2000-01-17 |
2008-04-16 |
Teijin Pharma Limited |
Derivados de bencimidazol como inhibidores de quimasa humana.
|
|
AU2001229491A1
(en)
|
2000-01-18 |
2001-07-31 |
Merck And Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
|
|
WO2001056592A1
(en)
|
2000-02-01 |
2001-08-09 |
Novo Nordisk A/S |
Use of compounds for the regulation of food intake
|
|
WO2001058869A2
(en)
|
2000-02-11 |
2001-08-16 |
Bristol-Myers Squibb Company |
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
|
|
JP2001226269A
(ja)
|
2000-02-18 |
2001-08-21 |
Takeda Chem Ind Ltd |
メラニン凝集ホルモン拮抗剤
|
|
WO2001062738A1
(en)
|
2000-02-22 |
2001-08-30 |
Banyu Pharmaceutical Co., Ltd. |
Novel imidazoline compounds
|
|
GB0004003D0
(en)
|
2000-02-22 |
2000-04-12 |
Knoll Ag |
Therapeutic agents
|
|
BR0108605A
(pt)
|
2000-02-23 |
2002-11-19 |
Aventis Pharma Gmbh |
Derivados de 8,8a-dihidro-indeno[1,2-d]tiazol, que na posição 8a são substituìdos; processos para a sua preparação e seu emprego como medicamentos, por exemplo, como anoréxicos
|
|
US6531478B2
(en)
|
2000-02-24 |
2003-03-11 |
Cheryl P. Kordik |
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
|
|
NZ520981A
(en)
|
2000-02-26 |
2004-08-27 |
Aventis Pharma Gmbh |
8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
|
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
|
BRPI0109200B8
(pt)
|
2000-03-14 |
2021-05-25 |
Actelion Pharmaceuticals Ltd |
compostos e composições farmacêuticas
|
|
JP2003527444A
(ja)
|
2000-03-23 |
2003-09-16 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体アゴニストとして作用するスピロピペリジン誘導体
|
|
DZ3335A1
(fr)
|
2000-03-23 |
2001-09-27 |
Solvay Pharm Bv |
Derives de 4,5-dihydro-1h-pyrazole ayant une activite antagoniste de cb1
|
|
WO2001070708A1
(en)
|
2000-03-23 |
2001-09-27 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin receptor agonists
|
|
US6600015B2
(en)
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
|
EP1142886A1
(en)
|
2000-04-07 |
2001-10-10 |
Aventis Pharma Deutschland GmbH |
Percyquinnin, a process for its production and its use as a pharmaceutical
|
|
JP2001354671A
(ja)
|
2000-04-14 |
2001-12-25 |
Nippon Chemiphar Co Ltd |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
WO2001079150A1
(en)
|
2000-04-17 |
2001-10-25 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
EP1285651B1
(en)
|
2000-04-28 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Melanin concentrating hormone antagonists
|
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0011013D0
(en)
|
2000-05-09 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
US6432960B2
(en)
|
2000-05-10 |
2002-08-13 |
Bristol-Myers Squibb Company |
Squarate derivatives of dihydropyridine NPY antagonists
|
|
AU2001263021A1
(en)
|
2000-05-10 |
2001-11-20 |
Bristol-Myers Squibb Company |
Alkylamine derivatives of dihydropyridine npy antagonists
|
|
US6444675B2
(en)
|
2000-05-10 |
2002-09-03 |
Bristol-Myers Squibb Company |
4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
|
|
ATE310728T1
(de)
|
2000-05-11 |
2005-12-15 |
Bristol Myers Squibb Co |
Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
|
|
JP2002371059A
(ja)
|
2000-05-16 |
2002-12-26 |
Takeda Chem Ind Ltd |
メラニン凝集ホルモン拮抗剤
|
|
US7229986B2
(en)
|
2000-05-16 |
2007-06-12 |
Takeda Pharmaceutical Company Ltd. |
Melanin-concentrating hormone antagonist
|
|
EP1286697A2
(en)
|
2000-05-17 |
2003-03-05 |
Eli Lilly And Company |
Method for selectively inhibiting ghrelin action
|
|
US6391881B2
(en)
|
2000-05-19 |
2002-05-21 |
Bristol-Myers Squibb Company |
Thiourea derivatives of dihydropyridine NPY antagonists
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
JP2003534377A
(ja)
|
2000-05-30 |
2003-11-18 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体作働薬
|
|
ES2291323T3
(es)
|
2000-06-15 |
2008-03-01 |
Schering Corporation |
Antagonistas de receptores de trombina.
|
|
ES2238458T3
(es)
|
2000-06-16 |
2005-09-01 |
Smithkline Beecham Plc |
Piperidinas para uso como antagonistas de los receptores de orexina.
|
|
EP1299362A4
(en)
|
2000-07-05 |
2004-11-03 |
Synaptic Pharma Corp |
SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
|
|
JP2004516239A
(ja)
|
2000-07-06 |
2004-06-03 |
ニューロジェン コーポレイション |
メラニン凝集ホルモン受容体リガンド
|
|
GB0019357D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel phenyl guanidines
|
|
CN1443198A
(zh)
|
2000-07-24 |
2003-09-17 |
阿达纳生物科学有限公司 |
Ghrelin拮抗剂
|
|
JP4180365B2
(ja)
|
2000-07-31 |
2008-11-12 |
エフ．ホフマン−ラ ロシュ アーゲー |
ピペラジン誘導体
|
|
US6768024B1
(en)
|
2000-08-04 |
2004-07-27 |
Lion Bioscience Ag |
Triamine derivative melanocortin receptor ligands and methods of using same
|
|
GB0019359D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel guanidines
|
|
WO2003024953A1
(en)
|
2000-08-10 |
2003-03-27 |
Nisshin Pharma Inc. |
Propanolamine derivative having 1,4-benzodioxane ring
|
|
JP4101053B2
(ja)
|
2000-08-10 |
2008-06-11 |
田辺三菱製薬株式会社 |
プロリン誘導体及びその医薬用途
|
|
EP1310494B1
(en)
|
2000-08-11 |
2012-01-25 |
Nippon Chemiphar Co., Ltd. |
PPAR (delta) ACTIVATORS
|
|
WO2002013821A1
(en)
|
2000-08-17 |
2002-02-21 |
Gliatech, Inc. |
Novel alicyclic imidazoles as h3 agents
|
|
US20040006120A1
(en)
|
2000-08-21 |
2004-01-08 |
Yates Stephen L |
Use of histamine h3 receptor inverse agonists for the control of appetite and treatment of obesity
|
|
US6680340B2
(en)
|
2000-08-21 |
2004-01-20 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
|
US20020037829A1
(en)
|
2000-08-23 |
2002-03-28 |
Aronson Peter S. |
Use of DPPIV inhibitors as diuretic and anti-hypertensive agents
|
|
JP2004506687A
(ja)
|
2000-08-23 |
2004-03-04 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体作働薬としての置換ピペリジン類
|
|
US6900226B2
(en)
|
2000-09-06 |
2005-05-31 |
Hoffman-La Roche Inc. |
Neuropeptide Y antagonists
|
|
CA2422013A1
(en)
|
2000-09-14 |
2002-03-21 |
Schering Corporation |
Substituted urea neuropeptide y y5 receptor antagonists
|
|
WO2002026707A1
(en)
|
2000-09-26 |
2002-04-04 |
Biovitrum Ab |
Novel compounds
|
|
AU2001292480A1
(en)
|
2000-09-26 |
2002-04-08 |
Biovitrum Ab |
Novel pyridazine compounds for the treatment of diabetes
|
|
HUP0301351A3
(en)
|
2000-10-13 |
2007-05-29 |
Lilly Co Eli |
Use of substituted dipeptides as growth hormone secretagogues, process for their preparation and pharmaceutical compositions containing them
|
|
AU2167002A
(en)
|
2000-10-16 |
2002-06-11 |
Hoffmann La Roche |
Indoline derivatives and their use as 5-ht2 receptor ligands
|
|
CN1469876A
(zh)
|
2000-10-20 |
2004-01-21 |
�Ʒ� |
α-芳基乙醇胺及其用作β-3肾上腺素能受体激动剂的用途
|
|
JP4734705B2
(ja)
|
2000-10-31 |
2011-07-27 |
三菱化学株式会社 |
リチウム二次電池用正極材料、リチウム二次電池用正極及びリチウム二次電池
|
|
AU2002227170A1
(en)
|
2000-11-03 |
2002-05-15 |
Wyeth |
Cycloalkyl(b)(1,4)diazepino(6,7,1-hi)indoles and derivatives
|
|
WO2002038544A2
(en)
|
2000-11-10 |
2002-05-16 |
Eli Lilly And Company |
3-substituted oxindole beta 3 agonists
|
|
AU2403802A
(en)
|
2000-11-15 |
2002-05-27 |
Banyu Pharma Co Ltd |
Benzimidazole derivatives
|
|
CA2448729A1
(en)
|
2000-11-20 |
2002-05-23 |
Biovitrum Ab |
Piperazinyl and piperidyl substituted heterocyclic compounds
|
|
NZ525699A
(en)
|
2000-11-20 |
2005-03-24 |
Biovitrum Ab |
Piperazinylpyrazines compounds as antagonists of serotonin 5-HT2 receptor
|
|
WO2002044172A1
(en)
|
2000-11-28 |
2002-06-06 |
Smithkline Beecham P.L.C. |
Morpholine derivatives as antagonists of orexin receptors
|
|
AU2002224139A1
(en)
|
2000-12-05 |
2002-06-18 |
Nippon Chemiphar Co. Ltd. |
Ppar (peroxisome proliferator activated receptor) activators
|
|
AU2002224138A1
(en)
|
2000-12-05 |
2002-06-18 |
Nippon Chemiphar Co. Ltd. |
Peroxisome proliferator activated receptor d activators
|
|
EP1347982B1
(en)
|
2000-12-12 |
2005-11-16 |
Neurogen Corporation |
Spiro isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
|
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
|
AU3405602A
(en)
|
2000-12-21 |
2002-07-01 |
Schering Corp |
Heteroaryl urea neuropeptide y y5 receptor antagonists
|
|
BR0116388A
(pt)
|
2000-12-22 |
2003-09-30 |
Astrazeneca Ab |
Composto, processo para preparar um composto, composição farmacêutica e método para tratar, em um animal de sangue quente, distúrbios de alimentação e uso de um composto
|
|
JP4025200B2
(ja)
|
2000-12-22 |
2007-12-19 |
シェーリング コーポレイション |
ピペリジンｍｃｈアンタゴニストおよび肥満の処置におけるそれらの使用
|
|
KR100539143B1
(ko)
|
2000-12-27 |
2005-12-26 |
에프. 호프만-라 로슈 아게 |
인돌 유도체 및 그의 5-ｈｔ2ｂ 및 5-ｈｔ2ｃ 수용체리간드로서의 용도
|
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
|
ES2247298T3
(es)
|
2001-01-23 |
2006-03-01 |
Eli Lilly And Company |
Derivados de piperazina y piperidina como agonistas del receptor de melanocortina.
|
|
EP1368339A1
(en)
|
2001-01-23 |
2003-12-10 |
Eli Lilly & Company |
Substituted piperidines/piperazines as melanocortin receptor agonists
|
|
CA2432988A1
(en)
|
2001-01-23 |
2002-08-01 |
Cristina Garcia-Paredes |
Melanocortin receptor agonists
|
|
SK10802003A3
(sk)
|
2001-02-02 |
2004-05-04 |
Takeda Chemical Industries, Ltd. |
Kondenzovaná heterocyklická zlúčenina, jej použitie a jej farmaceutický prípravok
|
|
JP2004534733A
(ja)
|
2001-02-05 |
2004-11-18 |
ドクター・レディーズ・ラボラトリーズ・リミテッド |
血中コレステロール低下剤剤としてのアリール置換アルキルカルボン酸
|
|
WO2002062766A2
(en)
|
2001-02-07 |
2002-08-15 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US20020119958A1
(en)
|
2001-02-13 |
2002-08-29 |
Shinichiro Tojo |
Therapeutic agent for hyperlipidemia
|
|
CA2437035C
(en)
|
2001-02-24 |
2009-01-06 |
International Business Machines Corporation |
Global interrupt and barrier networks
|
|
US7012084B2
(en)
|
2001-02-28 |
2006-03-14 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
|
CA2439152C
(en)
|
2001-02-28 |
2008-06-17 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
|
DE60215132T2
(de)
|
2001-02-28 |
2007-08-23 |
Merck & Co., Inc. |
Acylierte piperidin-derivate als melanocortin-4-rezeptor-agonisten
|
|
GB0105772D0
(en)
|
2001-03-08 |
2001-04-25 |
Sterix Ltd |
Use
|
|
IL157456A0
(en)
|
2001-03-21 |
2004-03-28 |
Pharmacopeia Inc Pharmacopeia |
Aryl and biaryl compounds having mch modulatory activity
|
|
US6900329B2
(en)
|
2001-03-21 |
2005-05-31 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
|
PL363751A1
(en)
|
2001-03-22 |
2004-11-29 |
Solvay Pharmaceuticals B.V. |
4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
|
|
US7078422B2
(en)
|
2001-03-23 |
2006-07-18 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator-activated receptor
|
|
US20050038022A1
(en)
|
2001-03-26 |
2005-02-17 |
Unisearch Limited |
Method for treatment of cancer and compositions for use therein
|
|
JP4256166B2
(ja)
|
2001-03-28 |
2009-04-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
カルボン酸化合物
|
|
AU782148B2
(en)
|
2001-03-29 |
2005-07-07 |
Molecular Design International, Inc. |
Beta3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
|
|
US7244861B2
(en)
|
2001-03-30 |
2007-07-17 |
Eisai Co., Ltd. |
Benzene compound and salt thereof
|
|
GB0108631D0
(en)
|
2001-04-05 |
2001-05-30 |
Melacure Therapeutics Ab |
Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
|
|
ATE460163T1
(de)
|
2001-04-12 |
2010-03-15 |
Pharmacopeia Llc |
Arly und diaryl piperidinderivate verwendbar als mch-hemmer
|
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
|
WO2002090355A1
(en)
|
2001-05-05 |
2002-11-14 |
Smithkline Beecham P.L.C. |
N-aroyl cyclic amines
|
|
WO2002089800A2
(en)
|
2001-05-05 |
2002-11-14 |
Smithkline Beecham P.L.C. |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
|
US7030150B2
(en)
|
2001-05-11 |
2006-04-18 |
Trimeris, Inc. |
Benzimidazole compounds and antiviral uses thereof
|
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP3715280B2
(ja)
|
2001-05-21 |
2005-11-09 |
エフ．ホフマン−ラ ロシュ アーゲー |
ニューロペプチドｙレセプターのリガンドとしてのキノリン誘導体
|
|
US6548538B2
(en)
|
2001-05-22 |
2003-04-15 |
Bayer Aktiengesellschaft |
Propionic acid derivatives
|
|
CA2448080A1
(en)
|
2001-05-22 |
2002-11-28 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
|
|
WO2002100833A1
(en)
|
2001-06-12 |
2002-12-19 |
Sumitomo Pharmaceuticals Company, Limited |
Rho KINASE INHIBITORS
|
|
ES2257555T3
(es)
|
2001-06-20 |
2006-08-01 |
MERCK & CO., INC. |
Inhibidores de dipeptidilpeptidasa para el tratamiento de la diabetes.
|
|
WO2003000685A1
(fr)
|
2001-06-20 |
2003-01-03 |
Takeda Chemical Industries, Ltd. |
Derives heterocycliques a 5 chainons
|
|
CA2450579A1
(en)
|
2001-06-20 |
2003-01-03 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
|
EP1405636A4
(en)
|
2001-06-26 |
2009-04-15 |
Takeda Pharmaceutical |
FUNCTIONAL REGULATOR FOR RETINOID RELATIVE RECEPTOR
|
|
SE0102299D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
|
CN1723196A
(zh)
|
2001-06-27 |
2006-01-18 |
史密丝克莱恩比彻姆公司 |
作为二肽酶抑制剂的氟代吡咯烷
|
|
JP4357293B2
(ja)
|
2001-06-27 |
2009-11-04 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類
|
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
|
ATE380175T1
(de)
|
2001-06-27 |
2007-12-15 |
Smithkline Beecham Corp |
Pyrrolidine als dipeptidyl peptidase inhibitoren
|
|
RU2003105463A
(ru)
|
2001-06-27 |
2004-11-27 |
Пробиодруг Аг (De) |
Пептидные структуры, пригодные для конкурентного модулирования катализа, осуществляемого дипептидилпептидазой iv
|
|
ATE304545T1
(de)
|
2001-06-29 |
2005-09-15 |
Novo Nordisk As |
Verfahren zur hemmung von tyrosinphosphatase 1b und/oder t-zellenprotein-tyrosinphosphatase und/oder anderen ptpasen mit einem asp-rest in position 48
|
|
US6688713B2
(en)
|
2001-07-02 |
2004-02-10 |
Mitsubishi Digital Electronics America, Inc. |
Television base casting
|
|
DE60225556D1
(de)
|
2001-07-03 |
2008-04-24 |
Novo Nordisk As |
Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
|
|
JP3532537B2
(ja)
|
2001-07-05 |
2004-05-31 |
株式会社テムコジャパン |
骨伝導ヘッドセット
|
|
CA2454613A1
(en)
|
2001-07-05 |
2003-01-16 |
Synaptic Pharmaceutical Corporation |
Substituted anilinic piperidines as mch selective antagonists
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
ITMI20011483A1
(it)
|
2001-07-11 |
2003-01-11 |
Res & Innovation Soc Coop A R |
Uso di composti come antagonisti funzionali ai recettori centrali deicannabinoidi
|
|
US6960646B2
(en)
|
2001-07-12 |
2005-11-01 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptors agonists
|
|
WO2003007990A1
(en)
|
2001-07-18 |
2003-01-30 |
Sumitomo Pharmaceuticals Company, Limited |
Myosin agonist
|
|
US7115628B2
(en)
|
2001-07-18 |
2006-10-03 |
Merck & Co., Inc. |
Bridged piperidine derivatives as melanocortin receptor agonists
|
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
US7115607B2
(en)
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
|
PL368201A1
(en)
|
2001-07-26 |
2005-03-21 |
Schering Corporation |
Substituted urea neuropeptide y y5 receptor antagonists
|
|
JP4301940B2
(ja)
|
2001-07-31 |
2009-07-22 |
日清オイリオグループ株式会社 |
抗肥満剤およびその原料
|
|
WO2003014113A1
(en)
|
2001-08-06 |
2003-02-20 |
Glenmark Pharmaceuticals Limited |
Novel benzopyran compounds and process for their preparation and use
|
|
GB0119172D0
(en)
|
2001-08-06 |
2001-09-26 |
Melacure Therapeutics Ab |
Phenyl pyrrole derivatives
|
|
HUP0401108A2
(hu)
|
2001-08-07 |
2004-09-28 |
Banyu Pharmaceutical Co., Ltd. |
Spirovegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
|
|
CA2456964A1
(en)
|
2001-08-08 |
2003-02-20 |
Merck & Co., Inc. |
Melanin-concentrating hormone antagonists
|
|
BRPI0211844B8
(pt)
|
2001-08-10 |
2021-05-25 |
Nippon Chemiphar Co |
composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
|
|
AU2002318206A1
(en)
|
2001-08-14 |
2003-03-03 |
Jolie Anne Bastian |
3-substituted oxindole beta-3 agonists
|
|
US7208505B2
(en)
|
2001-08-14 |
2007-04-24 |
Eli Lilly And Company |
β3 adrenergic agonists
|
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US7371777B2
(en)
|
2001-08-17 |
2008-05-13 |
Eisai Co., Ltd. |
Cyclic compound and PPAR agonist
|
|
US20030092041A1
(en)
|
2001-08-23 |
2003-05-15 |
Millennium Pharmaceuticals, Inc. |
Novel use for muscarinic receptor M5 in the diagnosis and treatment of metabolic disorders
|
|
JP4173098B2
(ja)
|
2001-08-24 |
2008-10-29 |
帝人株式会社 |
キマーゼ阻害剤及びａｃｅ阻害剤を有効成分として含有する薬剤
|
|
CA2457922A1
(en)
|
2001-08-31 |
2003-03-13 |
University Of Connecticut |
Novel pyrazole analogs acting on cannabinoid receptors
|
|
GB0121941D0
(en)
|
2001-09-11 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
US6915444B2
(en)
|
2001-09-12 |
2005-07-05 |
Rockwell Automation Technologies, Inc. |
Network independent safety protocol for industrial controller using data manipulation techniques
|
|
KR20040033048A
(ko)
|
2001-09-14 |
2004-04-17 |
미츠비시 웰파마 가부시키가이샤 |
티아졸리딘 유도체 및 이의 약학적 용도
|
|
FR2829765A1
(fr)
*
|
2001-09-14 |
2003-03-21 |
Lipha |
Derives imidazolylalkoxylarylalcanoiques leurs applications en therapeutique
|
|
US6780859B2
(en)
|
2001-09-14 |
2004-08-24 |
Bayer Pharmaceuticals Corporation |
Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
|
|
EP1434765B1
(en)
|
2001-09-14 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
Substituted piperidines with selective binding to histamine h3-receptor
|
|
ATE479655T1
(de)
|
2001-09-14 |
2010-09-15 |
High Point Pharmaceuticals Llc |
Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
|
|
BR0212512A
(pt)
|
2001-09-14 |
2004-10-26 |
Tularik Inc |
Composto, composição farmacêutica e métodos para tratar um distúrbio, condição ou doença, elevar os nìveis do colesterol hdl, reduzir os nìveis de triglicerìdeo, tratar diabete, diminuir a resistência à insulina ou diminuir a pressão arterial e modular a ppardelta
|
|
AU2002331311A1
(en)
|
2001-09-19 |
2003-04-01 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
|
WO2003024447A1
(en)
|
2001-09-20 |
2003-03-27 |
Smithkline Beecham Corporation |
Inhibitors of glycogen synthase kinase-3
|
|
IL157704A0
(en)
|
2001-09-21 |
2004-03-28 |
Solvay Pharm Bv |
4,5-dihydro-1h-pyrazole derivatives having potent cbi-antagonistic activity
|
|
KR100903760B1
(ko)
|
2001-09-21 |
2009-06-19 |
솔베이 파마슈티칼스 비. 브이 |
Ｃｂ1-길항 작용을 가지는 신규한4,5-디하이드로-1ｈ-피라졸 유도체
|
|
TWI231757B
(en)
|
2001-09-21 |
2005-05-01 |
Solvay Pharm Bv |
1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
|
CN100350968C
(zh)
|
2001-09-24 |
2007-11-28 |
皇家创新有限公司 |
饮食行为的改进
|
|
AU2002331898A1
(en)
|
2001-09-24 |
2003-04-07 |
Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College |
Induction of brown adipocytes by transcription factor nfe2l2
|
|
MXPA04002249A
(es)
|
2001-09-24 |
2004-06-29 |
Bayer Pharmaceuticals Corp |
Preparacion y uso de derivados de 1,5,6,7,-tetrahidro-pirrolo[3,2-c]piridina para el tratamiento de la obesidad.
|
|
MXPA04002438A
(es)
|
2001-09-24 |
2004-06-29 |
Bayer Pharmaceuticals Corp |
Preparacion y uso de derivados de pirroll para el tratamiento de la obesidad.
|
|
UY27450A1
(es)
|
2001-09-24 |
2003-04-30 |
Bayer Corp |
Preparación y uso de derivados de imidazol para el tratamiento de la obesidad
|
|
CN1578781A
(zh)
|
2001-09-26 |
2005-02-09 |
拜尔药品公司 |
用作抗糖尿病药物的1,8－萘啶衍生物
|
|
US6787558B2
(en)
|
2001-09-28 |
2004-09-07 |
Hoffmann-La Roche Inc. |
Quinoline derivatives
|
|
EP1432693A2
(en)
|
2001-10-01 |
2004-06-30 |
Taisho Pharmaceutical Co. Ltd. |
Mch receptor antagonists
|
|
US7119110B2
(en)
|
2001-10-05 |
2006-10-10 |
Interhealth Nutraceuticals Incorporated |
Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
|
|
WO2003031408A2
(en)
|
2001-10-08 |
2003-04-17 |
Eli Lilly And Company |
Tricyclic compounds useful for modulating lxr
|
|
EP1465867A1
(en)
|
2001-10-09 |
2004-10-13 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
PT1445258E
(pt)
|
2001-10-12 |
2009-07-02 |
Nippon Chemiphar Co |
Activador para o receptor delta activado por proliferador de peroxissoma
|
|
US6573396B2
(en)
|
2001-10-12 |
2003-06-03 |
Exxonmobil Chemical Patents Inc. |
Co-production of dialkyl carbonates and diols with treatment of hydroxy alkyl carbonate
|
|
JP2005507932A
(ja)
|
2001-10-12 |
2005-03-24 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
肥満の処置のためのフェニル置換５−員窒素含有複素環
|
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
|
IL161429A0
(en)
|
2001-10-16 |
2004-09-27 |
Reddys Lab Ltd Dr |
Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the same
|
|
CN1571766A
(zh)
|
2001-10-17 |
2005-01-26 |
诺沃挪第克公司 |
二羧酸衍生物、其制备和治疗应用
|
|
DE10151390A1
(de)
|
2001-10-18 |
2003-05-08 |
Bayer Ag |
Essigsäurederivate
|
|
CN1585751A
(zh)
|
2001-10-25 |
2005-02-23 |
武田药品工业株式会社 |
喹啉化合物
|
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
|
US20050054696A1
(en)
|
2001-10-29 |
2005-03-10 |
Takeshi Nakamura |
Indole compounds and medicinal use thereof
|
|
US7342117B2
(en)
|
2001-10-30 |
2008-03-11 |
Astellas Pharma Inc. |
α-form or β-form crystal of acetanilide derivative
|
|
ES2294190T3
(es)
|
2001-11-01 |
2008-04-01 |
Janssen Pharmaceutica N.V. |
Derivados de amida como inhibidores de la glucogeno sintasa quinasa 3-beta.
|
|
GB0126292D0
(en)
|
2001-11-01 |
2002-01-02 |
Smithkline Beecham Plc |
Compounds
|
|
HUP0402106A3
(en)
|
2001-11-01 |
2009-07-28 |
Janssen Pharmaceutica Nv |
Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors, process for their preparation and pharmaceutical compositions containing them
|
|
JP2005508978A
(ja)
|
2001-11-02 |
2005-04-07 |
ファイザー・プロダクツ・インク |
Ｐｄｅ９阻害薬によるインスリン抵抗性症候群及び２型糖尿病の治療
|
|
HN2002000317A
(es)
|
2001-11-02 |
2003-05-21 |
Pfizer |
Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
|
|
EP1442028A4
(en)
|
2001-11-06 |
2009-11-04 |
Bristol Myers Squibb Co |
SUBSTITUTED ACID DERIVATIVES, WHICH APPRECIATE AS ANTIDIBILICS AND AGENTS AGAINST OBESITAS, AND METHODS
|
|
AU2002349705A1
(en)
|
2001-12-03 |
2003-06-17 |
Japan Tobacco Inc. |
Azole compound and medicinal use thereof
|
|
PL370989A1
(en)
|
2001-12-21 |
2005-06-13 |
Novo Nordisk A/S |
Amide derivatives as gk activators
|
|
AU2002360732A1
(en)
|
2001-12-26 |
2003-07-24 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
|
WO2003057698A2
(en)
|
2001-12-28 |
2003-07-17 |
Acadia Pharmaceuticals, Inc. |
Spiroazacyclic compounds as monoamine receptor modulators
|
|
US20050113283A1
(en)
|
2002-01-18 |
2005-05-26 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-4 receptor
|
|
CA2473740A1
(en)
|
2002-01-18 |
2003-07-31 |
David Solow-Cordero |
Methods of treating conditions associated with an edg receptor
|
|
CA2474702A1
(en)
|
2002-01-30 |
2003-08-07 |
Tularik Inc |
Heterocyclic arylsulfonamidobenzylic compounds
|
|
WO2003064404A1
(en)
|
2002-02-01 |
2003-08-07 |
Dainippon Pharmaceutical Co., Ltd. |
2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
|
|
AU2003217274A1
(en)
|
2002-02-25 |
2003-09-09 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
EP1479666A4
(en)
|
2002-02-28 |
2010-10-13 |
Japan Tobacco Inc |
ESTER CONNECTION AND THEIR MEDICAL USE
|
|
JP3813152B2
(ja)
|
2002-03-12 |
2006-08-23 |
メルク エンド カムパニー インコーポレーテッド |
置換アミド類
|
|
AU2003222278A1
(en)
*
|
2002-03-20 |
2003-10-08 |
Schering Aktiengesellschaft |
Menthol substituted antithrombotic pai-1 inhibitors
|
|
JPWO2003091216A1
(ja)
|
2002-04-25 |
2005-09-02 |
住友製薬株式会社 |
新規ピペリジン誘導体
|
|
WO2003091213A1
(en)
|
2002-04-25 |
2003-11-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel amide derivatives or salts thereof
|
|
AU2003230367A1
(en)
|
2002-05-10 |
2003-11-11 |
Neurocrine Biosciences, Inc. |
Substituted piperazine as melanocortin receptors ligands
|
|
DE10222034A1
(de)
|
2002-05-17 |
2003-11-27 |
Bayer Ag |
Tetrahydroisochinolin-Derivate
|
|
US20060148858A1
(en)
|
2002-05-24 |
2006-07-06 |
Tsuyoshi Maekawa |
1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity
|
|
DE60309909T2
(de)
|
2002-06-19 |
2007-06-21 |
Karo Bio Ab |
Glucocorticoidrezeptorliganden zur behandlung von stoffwechselstörungen
|
|
DE10229777A1
(de)
|
2002-07-03 |
2004-01-29 |
Bayer Ag |
Indolin-Phenylsulfonamid-Derivate
|
|
GB0215579D0
(en)
|
2002-07-05 |
2002-08-14 |
Astrazeneca Ab |
Chemical compounds
|
|
SE0202134D0
(sv)
|
2002-07-08 |
2002-07-08 |
Astrazeneca Ab |
Therapeutic agents
|
|
WO2004004611A1
(en)
|
2002-07-08 |
2004-01-15 |
Coloplast A/S |
Conduit device
|
|
CA2460051A1
(en)
|
2002-07-09 |
2004-01-15 |
Actelion Pharmaceuticals Ltd. |
7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo[2,1-b]-quinazolinone derivatives
|
|
JPWO2004007439A1
(ja)
|
2002-07-10 |
2005-11-10 |
住友製薬株式会社 |
ビアリール誘導体
|
|
EP1525304A1
(de)
|
2002-07-18 |
2005-04-27 |
Basf Aktiengesellschaft |
Nadh-abhängige cytochrom b5 reduktase als target für herbizide
|
|
DE10233817A1
(de)
|
2002-07-25 |
2004-02-12 |
Aventis Pharma Deutschland Gmbh |
Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US20050272036A1
(en)
|
2002-07-27 |
2005-12-08 |
Barton Peter J |
Ketones
|
|
JP4202319B2
(ja)
|
2002-07-29 |
2008-12-24 |
エフ．ホフマン−ラ ロシュ アーゲー |
新規ベンゾジオキソール
|
|
JP2004067629A
(ja)
|
2002-08-09 |
2004-03-04 |
Yamanouchi Pharmaceut Co Ltd |
ミトコンドリア機能活性化剤及び新規なベンゾイミダゾール誘導体
|
|
DE10238860A1
(de)
|
2002-08-24 |
2004-03-04 |
Bayerische Motoren Werke Ag |
Brennstoff-Zelle mit einer das Brenngas über der Elektroden-Oberfläche verteilenden perforierten Folie
|
|
US6849761B2
(en)
|
2002-09-05 |
2005-02-01 |
Wyeth |
Substituted naphthoic acid derivatives useful in the treatment of insulin resistance and hyperglycemia
|
|
AU2003261935A1
(en)
|
2002-09-06 |
2004-03-29 |
Takeda Pharmaceutical Company Limited |
Furan or thiophene derivative and medicinal use thereof
|
|
JP2006501820A
(ja)
|
2002-09-06 |
2006-01-19 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
修飾ｇｌｐ−１受容体アゴニストおよびそれらの薬理学的使用法
|
|
WO2004027047A2
(en)
|
2002-09-18 |
2004-04-01 |
Hanauske-Abel Hartmut M |
INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE AND USES THEREFOR
|
|
DE60309481T2
(de)
|
2002-09-18 |
2007-06-21 |
Glaxo Group Ltd., Greenford |
Cyclische n-aroylamine als orexinrezeptorantagonisten
|
|
US7045527B2
(en)
|
2002-09-24 |
2006-05-16 |
Amgen Inc. |
Piperidine derivatives
|
|
US20060183789A1
(en)
|
2002-09-25 |
2006-08-17 |
Lavanya Rajachandran |
Methods for preventing and treating obesity in patients with mc4 receptor mutations
|
|
BR0314864A
(pt)
|
2002-10-03 |
2005-08-02 |
Novartis Ag |
Compostos orgânicos
|
|
JPWO2004037859A1
(ja)
|
2002-10-11 |
2006-02-23 |
株式会社三和化学研究所 |
Ｇｌｐ−１誘導体及びその経粘膜吸収型製剤
|
|
WO2004033427A1
(en)
|
2002-10-11 |
2004-04-22 |
Astrazeneca Ab |
1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
|
|
AU2003263475A1
(en)
|
2002-10-11 |
2004-05-04 |
Koninklijke Philips Electronics N.V. |
A unit for and method of image conversion
|
|
JP4768265B2
(ja)
|
2002-10-15 |
2011-09-07 |
シンタ ファーマシューティカルズ コーポレーション |
新規化合物
|
|
WO2004037251A1
(en)
|
2002-10-24 |
2004-05-06 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
|
US6852748B1
(en)
|
2002-10-30 |
2005-02-08 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
|
|
WO2004041795A1
(en)
|
2002-10-30 |
2004-05-21 |
Guilford Pharmaceuticals Inc. |
Novel inhibitors of dipeptidyl peptidase iv
|
|
DE10250743A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
FR2846656B1
(fr)
|
2002-11-05 |
2004-12-24 |
Servier Lab |
Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
GB0225944D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
|
US20060058315A1
(en)
|
2002-11-07 |
2006-03-16 |
Astrazeneca Ab |
2-Oxo-ethanesulfonamide derivates
|
|
GB0225986D0
(en)
|
2002-11-07 |
2002-12-11 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2505322A1
(en)
|
2002-11-08 |
2004-05-21 |
Takeda Pharmaceutical Company Limited |
Receptor function regulator
|
|
WO2004043913A2
(en)
|
2002-11-08 |
2004-05-27 |
Trimeris, Inc. |
Hetero-substituted benzimidazole compounds and antiviral uses thereof
|
|
DE10251927A1
(de)
|
2002-11-08 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US20050143449A1
(en)
|
2002-11-15 |
2005-06-30 |
The Salk Institute For Biological Studies |
Non-steroidal farnesoid X receptor modulators and methods for the use thereof
|
|
EP1565437A1
(en)
|
2002-11-18 |
2005-08-24 |
Pfizer Products Inc. |
Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides
|
|
GB0226930D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0226931D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2004048345A2
(en)
|
2002-11-22 |
2004-06-10 |
Novo Nordisk A/S |
2,5-diketopiperazines for the treatment of obesity
|
|
CN1717585A
(zh)
|
2002-11-25 |
2006-01-04 |
Gni美国公司 |
利用微分方程从时序基因表达数据推断基因调控网络
|
|
GB0227813D0
(en)
|
2002-11-29 |
2003-01-08 |
Astrazeneca Ab |
Chemical compounds
|
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
|
US7365070B2
(en)
|
2002-12-04 |
2008-04-29 |
Ore Pharmaceuticals Inc. |
Modulators of melanocortin receptor
|
|
EP1572637A1
(en)
|
2002-12-11 |
2005-09-14 |
Eli Lilly And Company |
Novel mch receptor antagonists
|
|
JP2004196702A
(ja)
|
2002-12-18 |
2004-07-15 |
Yamanouchi Pharmaceut Co Ltd |
新規なアミド誘導体又はその塩
|
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
|
US20040209928A1
(en)
|
2002-12-30 |
2004-10-21 |
Ravi Kurukulasuriya |
Glucagon receptor antagonists/inverse agonists
|
|
AU2003294376A1
(en)
|
2003-01-06 |
2004-08-10 |
Eli Lilly And Company |
Heteroaryl compounds
|
|
DE60336850D1
(en)
|
2003-01-06 |
2011-06-01 |
Lilly Co Eli |
Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
|
|
DE10301788B4
(de)
|
2003-01-20 |
2005-08-25 |
Aventis Pharma Deutschland Gmbh |
Pharmazeutische Verwendung von Pyrimido[5,4-e][1,2,4]triazin-5,7-dionen
|
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
|
JP4184378B2
(ja)
|
2003-01-31 |
2008-11-19 |
株式会社三和化学研究所 |
ジペプチジルペプチダーゼｉｖを阻害する化合物
|
|
US6759546B1
(en)
|
2003-02-04 |
2004-07-06 |
Allergan, Inc. |
3,5-di-iso-propyl-heptatrienoic acid derivatives having serum glucose reducing activity
|
|
WO2004072041A1
(en)
|
2003-02-12 |
2004-08-26 |
Care X S.A. |
Tetrahydroquinolines as agonists of liver- x receptors
|
|
CA2514363A1
(en)
|
2003-02-12 |
2004-08-26 |
Transtech Pharma, Inc. |
Substituted azole derivatives as therapeutic agents
|
|
WO2004071454A2
(en)
|
2003-02-13 |
2004-08-26 |
Guilford Pharmaceuticals Inc. |
Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv
|
|
US20050154011A1
(en)
|
2003-02-20 |
2005-07-14 |
The Procter & Gamble Company |
Tetrahydroisoquinolnyl sulfamic acids
|
|
FR2851563B1
(fr)
|
2003-02-26 |
2005-04-22 |
Sod Conseils Rech Applic |
Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
|
|
US20040224992A1
(en)
|
2003-02-27 |
2004-11-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
EP1468999A1
(en)
|
2003-03-20 |
2004-10-20 |
MyoContract Ltd. |
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
|
|
EP1460069A1
(en)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
|
|
CL2004000553A1
(es)
|
2003-03-20 |
2005-02-04 |
Actelion Pharmaceuticals Ltd |
Uso de compuestos derivados de guanidina como antagonistas del receptor de neuropeptido ff; compuestos derivados de guanidina; procedimientos de preparacion; y composicion farmaceutica que los comprende.
|
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
|
ES2327737T3
(es)
|
2003-03-26 |
2009-11-03 |
Actelion Pharmaceuticals Ltd. |
Derivados de tetrahidroisoquinolil acetamida para uso como antagonistas de receptores de orexina.
|
|
FR2852957B1
(fr)
|
2003-03-31 |
2005-06-10 |
Sod Conseils Rech Applic |
Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament
|
|
CN100475793C
(zh)
|
2003-03-31 |
2009-04-08 |
大正制药株式会社 |
喹唑啉衍生物及其制备药物的用途
|
|
JP2004315511A
(ja)
|
2003-03-31 |
2004-11-11 |
Taisho Pharmaceut Co Ltd |
Ｍｃｈ受容体アンタゴニスト
|
|
US20040199842A1
(en)
|
2003-04-04 |
2004-10-07 |
Sartschev Ronald A. |
Test system with high accuracy time measurement system
|
|
US20070027073A1
(en)
|
2003-04-08 |
2007-02-01 |
Menachem Rubinstein |
Long-acting derivatives of pyy agonists
|
|
WO2004089918A1
(ja)
|
2003-04-09 |
2004-10-21 |
Japan Tobacco Inc. |
複素芳香５員環化合物及びその医薬用途
|
|
GB0308335D0
(en)
|
2003-04-10 |
2003-05-14 |
Novartis Ag |
Organic compounds
|
|
JP2006522744A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
グルココルチコイド受容体アゴニスト療法に伴う副作用を最小化するための、１１β−ヒドロキシステロイドデヒドロゲナーゼ１型阻害剤およびグルココルチコイド受容体アゴニストを使用する併用療法
|
|
EA200501607A1
(ru)
|
2003-04-14 |
2006-06-30 |
ДЗЕ ИНСТИТЬЮТС ФОР ФАРМАСЬЮТИКАЛ ДИСКАВЕРИ, ЭлЭлСи |
Замещённые фенилалкановые кислоты
|
|
EP1620427A1
(en)
|
2003-04-17 |
2006-02-01 |
Pfizer Products Inc. |
Carboxamide derivatives as anti-diabetic agents
|
|
WO2004096768A1
(en)
|
2003-04-30 |
2004-11-11 |
Pfizer Products Inc. |
Anti-diabetic agents
|
|
AU2004234125A1
(en)
|
2003-05-01 |
2004-11-11 |
Vernalis Research Limited |
Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders
|
|
AU2003902260A0
(en)
|
2003-05-09 |
2003-05-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
US7119205B2
(en)
|
2003-05-16 |
2006-10-10 |
Abbott Laboratories |
Thienopyridones as AMPK activators for the treatment of diabetes and obesity
|
|
AU2003902828A0
(en)
|
2003-06-05 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
WO2004108674A1
(ja)
|
2003-06-05 |
2004-12-16 |
Kissei Pharmaceutical Co., Ltd. |
アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途
|
|
CN1802351A
(zh)
|
2003-06-11 |
2006-07-12 |
麦克公司 |
被取代的3－烷基和3－链烯基氮杂环丁烷衍生物
|
|
WO2004111004A1
(en)
|
2003-06-12 |
2004-12-23 |
Novo Nordisk A/S |
Substituted piperazine carbamates for use as inhibitors of hormone sensitive lipase
|
|
GB0314049D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
|
GB0314057D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
|
CA2527033A1
(en)
|
2003-06-18 |
2004-12-23 |
Astrazeneca Ab |
2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators
|
|
GB0314261D0
(en)
|
2003-06-19 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
|
EP1644023A2
(en)
|
2003-06-19 |
2006-04-12 |
Eli Lilly And Company |
Melanocortin recptor 4(mc4) agonists and their uses
|
|
RU2344132C2
(ru)
|
2003-06-20 |
2009-01-20 |
Ф.Хоффманн-Ля Рош Аг |
2-аминобензотиазолы в качестве обратных агонистов рецепторов cb1
|
|
US7355049B2
(en)
|
2003-06-24 |
2008-04-08 |
Hoffmann-La Roche Inc. |
Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
|
|
GB0314967D0
(en)
|
2003-06-26 |
2003-07-30 |
Hoffmann La Roche |
Piperazine derivatives
|
|
EP1638557A4
(en)
|
2003-06-27 |
2007-11-07 |
Univ Tel Aviv Future Tech Dev |
INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3
|
|
CN1816530A
(zh)
|
2003-07-01 |
2006-08-09 |
麦克公司 |
用于治疗高眼压症的眼用组合物
|
|
ATE411980T1
(de)
|
2003-07-21 |
2008-11-15 |
Smithkline Beecham Corp |
(2s,4s)-4-fluor-1-ä4-fluor-beta-(4-fluorphenyl) l-phenylalanylü-2-pyrrolidincarbonitril-p- toluolsulfonsäuresalz und wasserfreie kristalline formen davon
|
|
EP1648455A4
(en)
|
2003-07-23 |
2009-03-04 |
Exelixis Inc |
MODULATORS OF ALK PROTEIN (ANAPLASTIC LYMPHOMA KINASE) AND METHODS OF USE
|
|
JP2005042839A
(ja)
|
2003-07-23 |
2005-02-17 |
Iseki & Co Ltd |
作業車両の変速制御装置
|
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
|
AU2004261329B2
(en)
|
2003-07-31 |
2011-10-27 |
Ocera Therapeutics, Inc. |
Spatially-defined macrocyclic compounds useful for drug discovery
|
|
GB0318463D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0318464D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
|
US20070161582A1
(en)
|
2003-08-08 |
2007-07-12 |
Dusan Mijikovic |
Pharmaceutical compositions and methods for metabolic modulation
|
|
RU2006107444A
(ru)
|
2003-08-12 |
2007-09-20 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
2-амино-5-бензоилтиазолы в качестве антагонистов npy
|
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
|
US20050148643A1
(en)
|
2003-08-19 |
2005-07-07 |
Agouron Pharmaceuticals, Inc. |
Carbamate compositions and methods fo rmodulating the activity of the CHK1 enzyme
|
|
WO2005019168A2
(en)
|
2003-08-20 |
2005-03-03 |
Pfizer Products Inc. |
Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
|
|
KR20060120601A
(ko)
|
2003-08-22 |
2006-11-27 |
데이진 화-마 가부시키가이샤 |
키마제 저해제를 유효 성분으로서 함유하는 약제
|
|
TWI290140B
(en)
|
2003-08-25 |
2007-11-21 |
Schering Corp |
2-Substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for thr treatment of obesity and related disorders
|
|
RU2358975C2
(ru)
|
2003-08-26 |
2009-06-20 |
Тейдзин Фарма Лимитед |
Пирролопиримидиноновые производные
|
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
|
WO2005028624A2
(en)
|
2003-09-15 |
2005-03-31 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
|
US7030113B2
(en)
*
|
2003-10-02 |
2006-04-18 |
Schering Corporation |
Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
|
|
US20050107374A1
(en)
|
2003-10-21 |
2005-05-19 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
EP1677791A4
(en)
|
2003-10-31 |
2007-08-15 |
Takeda Pharmaceutical |
NITROGENIC CONDENSED HETEROCYCLIC COMPOUNDS
|
|
CA2545942C
(en)
|
2003-11-14 |
2012-07-10 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
|
CN1882327A
(zh)
|
2003-11-19 |
2006-12-20 |
症变治疗公司 |
含磷的新的拟甲状腺素药
|
|
TW200522944A
(en)
|
2003-12-23 |
2005-07-16 |
Lilly Co Eli |
CB1 modulator compounds
|
|
CA2551909C
(en)
|
2004-02-12 |
2011-10-11 |
Transtech Pharma, Inc. |
Substituted azole derivatives, compositions, and methods of use
|
|
RU2358969C2
(ru)
|
2004-02-13 |
2009-06-20 |
Баниу Фармасьютикал Ко., Лтд. |
Конденсированное 4-оксопиримидиновое производное
|
|
US7393847B2
(en)
*
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
|
CA2562082C
(en)
|
2004-04-13 |
2013-06-25 |
Merck & Co., Inc. |
Cetp inhibitors for the treatment and prevention of atherosclerosis
|
|
US7097961B2
(en)
|
2004-05-17 |
2006-08-29 |
Agfa Gevaert |
Stabilizers for use in substantially light-insensitive thermographic recording materials
|
|
US7687638B2
(en)
|
2004-06-04 |
2010-03-30 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
|
WO2005121132A1
(ja)
|
2004-06-11 |
2005-12-22 |
Shionogi & Co., Ltd. |
抗ｈｃｖ作用を有する縮合ヘテロ環化合物
|
|
DE102004028862A1
(de)
*
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
DOP2005000123A
(es)
|
2004-07-02 |
2011-07-15 |
Merck Sharp & Dohme |
Inhibidores de cetp
|
|
US7732479B2
(en)
|
2004-08-19 |
2010-06-08 |
Tel Aviv University Future Technology Development L.P. |
Compositions for treating amyloid associated diseases
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
US20080021069A1
(en)
*
|
2004-10-08 |
2008-01-24 |
Takeda Pharmaceutical Company Limited |
Receptor Function Regulating Agent
|
|
WO2006048159A1
(en)
|
2004-11-02 |
2006-05-11 |
Dsm Ip Assets B.V. |
Additive for uv-sunscreen preparations
|
|
EP1828144A2
(en)
|
2004-11-12 |
2007-09-05 |
OSI Pharmaceuticals, Inc. |
Integrin antagonists useful as anticancer agents
|
|
US20090286838A1
(en)
|
2004-12-06 |
2009-11-19 |
Newsouth Innovations Pty Limited |
Treatment for cancer
|
|
US7429608B2
(en)
|
2005-01-20 |
2008-09-30 |
Amgen Inc. |
Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments
|
|
WO2006094209A2
(en)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
N-benzimidazolylalkyl-substituted amide sirtuin modulators
|
|
US20060223849A1
(en)
|
2005-03-14 |
2006-10-05 |
Mjalli Adnan M |
Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
|
|
TWI370820B
(en)
|
2005-04-27 |
2012-08-21 |
Takeda Pharmaceutical |
Fused heterocyclic compounds
|
|
AU2006250354A1
(en)
|
2005-05-23 |
2006-11-30 |
Japan Tobacco Inc. |
Pyrazole compound and therapeutic agent for diabetes comprising the same
|
|
ATE441645T1
(de)
|
2005-05-25 |
2009-09-15 |
Actelion Pharmaceuticals Ltd |
Neue antibiotische derivate
|
|
WO2007005785A1
(en)
|
2005-07-04 |
2007-01-11 |
Dr. Reddy's Laboratories Ltd. |
Thiazoles derivatives as ampk activator
|
|
US20090278115A1
(en)
|
2005-07-11 |
2009-11-12 |
Idemitsu Kosan Co., Ltd. |
Nitrogen-containing heterocyclic derivative and organic electroluminescence element using the same
|
|
JPWO2007007463A1
(ja)
|
2005-07-11 |
2009-01-29 |
出光興産株式会社 |
電子吸引性置換基を有する含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
|
|
JP2007039406A
(ja)
|
2005-08-05 |
2007-02-15 |
Idemitsu Kosan Co Ltd |
含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
|
|
JP2007153778A
(ja)
|
2005-12-02 |
2007-06-21 |
Idemitsu Kosan Co Ltd |
含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
|
|
JP2009525955A
(ja)
|
2006-01-13 |
2009-07-16 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
CN101379060B
(zh)
|
2006-02-10 |
2012-05-23 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
CA2641880C
(en)
|
2006-02-10 |
2014-09-09 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
|
FR2903695B1
(fr)
|
2006-07-13 |
2008-10-24 |
Merck Sante Soc Par Actions Si |
Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
AU2007272795A1
(en)
|
2006-07-14 |
2008-01-17 |
Merck & Co., Inc. |
2-substituted proline bis-amide orexin receptor antagonists
|
|
EP1878724A1
(en)
|
2006-07-15 |
2008-01-16 |
sanofi-aventis |
A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
JP5294872B2
(ja)
|
2006-11-20 |
2013-09-18 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子
|
|
US7825261B2
(en)
|
2006-12-05 |
2010-11-02 |
National Taiwan University |
Indazole compounds
|
|
CA2685540C
(en)
|
2007-08-03 |
2018-10-16 |
Graham Michael Wynne |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
CA2714181C
(en)
|
2008-02-04 |
2013-12-24 |
Mercury Therapeutics, Inc. |
Ampk modulators
|
|
US8394969B2
(en)
*
|
2008-09-26 |
2013-03-12 |
Merck Sharp & Dohme Corp. |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
EP2348857B1
(en)
|
2008-10-22 |
2016-02-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
EP2352374B1
(en)
|
2008-10-29 |
2014-09-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
US8329914B2
(en)
|
2008-10-31 |
2012-12-11 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
SG192941A1
(en)
|
2011-02-25 |
2013-09-30 |
Merck Sharp & Dohme |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|